Swastika Investmart recommends investors consider subscribing to the IPO for the long term, citing the company's robust financial performance, growth, and improving profit margins. The firm emphasizes that IKS is a prominent partner in outpatient and inpatient care, with no comparable listed peers.
International Gemmological Institute IPO subscribed 72% on Day 2. Check GMP, other details
The Economic TimesFinal Hours! IKS IPO closes today: Subscription zooms 4x, GMP up 30%
Business StandardIGI IPO closes today: Check subscription status, GMP, and listing schedule
Business StandardInventurus Knowledge Solutions IPO Day 3 Live Updates: Issue subscribed 52.68x, check IKS IPO GMP, review, more
MintInternational Gemmological Institute IPO day 2: GMP, subscription status to review. Apply or not?
MintInternational Gemmological Institute IPO Day 3: GMP, subscription status, review & other details. Apply or not?
Mint
